NCT00837746 - Analysis of Iliac Crest Biopsies From Patients Receiving Risedronate | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions

Osteoporosis

Interventions

DRUG

risedronate

risedronate tablet, 5 mg daily or 35 mg once weekly for 5 years

Trial Locations (8)

Ronald D Emkey, MD, Wyomissing

Grattan Woodson, MD, Decatur

Christopher Recknor, MD, Gainesville

Nelson Watts, MD, Cincinnati

Robert Recker, MD, Omaha

Paul Miller, MD, Lakewood

Maria Greenwald, MD, Palm Desert

Louis-Georges Ste-Marie, MD, Montreal